{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:49:44Z","timestamp":1791409784077,"version":"4.3.3"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioorg.2026.110384","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T23:35:14Z","timestamp":1787268914000},"page":"110384","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design, one-pot synthesis, and structural characterization of novel 2-ureido-6-nitrobenzamide derivatives as MTDLs targeting HDAC8\/epigenetic-kinase networks"],"prefix":"10.1016","volume":"181","author":[{"given":"Mahmoud","family":"Farouk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salsabil","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahamad","family":"Imran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sama","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bioorg.2026.110384_bb0005","article-title":"Novel therapeutic agents in clinical trials: emerging approaches in cancer therapy. Discover","volume":"15","author":"Joshi","year":"2024","journal-title":"Oncology"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110384_bb0010","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3390\/pharmaceutics16020175","article-title":"Improving the Efficacy of Common Cancer Treatments via Targeted Therapeutics towards the Tumour and Its Microenvironment","volume":"16","author":"Cecchi","year":"2024","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110384_bb0015","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/carcin\/bgp263","article-title":"The global burden of cancer: priorities for prevention","volume":"31","author":"Thun","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bioorg.2026.110384_bb0020","doi-asserted-by":"crossref","first-page":"18593","DOI":"10.1039\/D5RA01077B","article-title":"Benzimidazole chemistry in oncology: recent developments in synthesis, activity, and SAR analysis","volume":"3, 15 (23)","author":"Farag","year":"2025","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2026.110384_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114954","article-title":"Structure activity relationship (SAR) and anticancer activity of pyrrolidine derivatives: Recent developments and future prospects (A review)","volume":"246","author":"Bhat","year":"2023","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"20","key":"10.1016\/j.bioorg.2026.110384_bb0030","doi-asserted-by":"crossref","first-page":"9970","DOI":"10.3390\/ijms26209970","article-title":"Comprehensive Structure-Activity Relationship Analysis of Benzamide Derivatives as Histone Deacetylase 1 (HDAC1) Inhibitors","volume":"26","author":"Soto-Delgado","year":"2025","journal-title":"International Journal of Molecular Sciences"},{"issue":"4","key":"10.1016\/j.bioorg.2026.110384_bb0035","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/13543776.2024.2363890","article-title":"HDAC3 inhibitors: a patent review of their broad-spectrum applications as therapeutic agents","volume":"34","author":"Makgoba","year":"2024","journal-title":"Expert Opinion on Therapeutic Patents"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110384_bb0040","article-title":"Exploring the role of histone deacetylase and histone deacetylase inhibitors in the context of multiple myeloma: mechanisms, therapeutic implications, and future perspectives. Experimental Hematology & Amp","volume":"13","author":"Pu","year":"2024","journal-title":"Oncology"},{"issue":"9","key":"10.1016\/j.bioorg.2026.110384_bb0045","doi-asserted-by":"crossref","first-page":"859","DOI":"10.4155\/fmc-2023-0122","article-title":"Key structural requirements of benzamide derivatives for histone deacetylase inhibition: design, synthesis and biological evaluation","volume":"16","author":"Cheshmazar","year":"2024","journal-title":"Future Medicinal Chemistry"},{"key":"10.1016\/j.bioorg.2026.110384_bb0050","doi-asserted-by":"crossref","DOI":"10.1007\/s12272-015-0673-9","article-title":"Strategy for enhancing the therapeutic efficacy of histone deacetylase inhibitor dacinostat: the novel paradigm to tackle monotonous cancer chemoresistance","author":"Ganai","year":"2015","journal-title":"Archives of Pharmacal Research."},{"issue":"10","key":"10.1016\/j.bioorg.2026.110384_bb0055","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1158\/1541-7786.MCR-07-0324","article-title":"Histone Deacetylase Inhibitors: Overview and Perspectives","volume":"5","author":"Dokmanovic","year":"2007","journal-title":"Molecular Cancer Research"},{"issue":"9","key":"10.1016\/j.bioorg.2026.110384_bb0060","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd2133","article-title":"Anticancer activities of histone deacetylase inhibitors","volume":"5","author":"Bolden","year":"2006","journal-title":"Nature Reviews Drug Discovery"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110384_bb0065","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/jcb.20532","article-title":"Prospects: Histone deacetylase inhibitors","volume":"96","author":"Dokmanovic","year":"2005","journal-title":"Journal of Cellular Biochemistry"},{"key":"10.1016\/j.bioorg.2026.110384_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108788","article-title":"N-substituted phthalimide\u2013carboxylic acid hybrids as dual-targeted aldose reductase inhibitors: Synthesis, mechanistic insights, and cancer-relevant profiling","volume":"163","author":"Zognjani","year":"2025","journal-title":"Bioorganic Chemistry"},{"issue":"17","key":"10.1016\/j.bioorg.2026.110384_bb0075","doi-asserted-by":"crossref","first-page":"5044","DOI":"10.1158\/1078-0432.CCR-17-1043","article-title":"Dual Inhibition of HDAC and Tyrosine Kinase Signaling Pathways with CUDC-907 Inhibits Thyroid Cancer Growth and Metastases","volume":"23","author":"Kotian","year":"2017","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.bioorg.2026.110384_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1244597","article-title":"Small-molecule inhibitors of kinases in breast cancer therapy: recent advances, opportunities, and challenges","volume":"14","author":"Bansal","year":"2023","journal-title":"Frontiers in Pharmacology"},{"issue":"11","key":"10.1016\/j.bioorg.2026.110384_bb0085","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.4155\/fmc-2017-0067","article-title":"Aminoisoquinoline Benzamides, Flt3 and Src-Family Kinase Inhibitors, Potently Inhibit Proliferation of Acute Myeloid Leukemia Cell Lines","volume":"9","author":"Larocque","year":"2017","journal-title":"Future Medicinal Chemistry"},{"issue":"17","key":"10.1016\/j.bioorg.2026.110384_bb0090","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.3390\/molecules30173584","article-title":"Discovery of Novel Benzamide-Based Sigma-1 Receptor Agonists with Enhanced Selectivity and Safety","volume":"30","author":"Carato","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110384_bb0095","doi-asserted-by":"crossref","unstructured":"Kundu, S, Akkoc, S, Erzurumlu, Y, Alhag, SK, Alkeridis, LA & Feizi-Dehnayebi, M 2026, \u201cSynthesis and multilevel evaluation of benzimidazole-based anticancer compounds: DNA\/serum albumin interaction, and in-depth theoretical insights,\u201d (ed.), Molecular and Cellular Biochemistry, accessed https:\/\/doi.org\/10.1007\/s11010-026-05600-3.","DOI":"10.1007\/s11010-026-05600-3"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110384_bb0100","article-title":"Combined experimental and theoretical investigation of the (benzoimidazol-2-yl)-methanone ligand and its Ru(III) complex: structural elucidation, stability determination, corrosion inhibition, energy storage and bioactivity applications. BMC","volume":"20","author":"Shilkamy","year":"2026","journal-title":"Chemistry"},{"issue":"19","key":"10.1016\/j.bioorg.2026.110384_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202500521","article-title":"Synthesis of Urea\u2010Containing Derivatives and their Application as Potential Anti\u2010Methicillin\u2010Resistant Staphylococcus Aureus Agents","volume":"20","author":"Gonz\u00e1lez\u2010Cruz","year":"2025","journal-title":"ChemMedChem"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110384_bb0110","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s11030-021-10249-9","article-title":"New benzamide derivatives and their nicotinamide\/cinnamamide analogs as cholinesterase inhibitors","volume":"26","author":"Koca","year":"2021","journal-title":"Molecular Diversity"},{"key":"10.1016\/j.bioorg.2026.110384_bb0115","doi-asserted-by":"crossref","unstructured":"Tugrak, M., Gul, H. I., Demir, Y., & Gulcin, I. (2020). Synthesis of benzamide derivatives with thiourea\u2010substituted benzenesulfonamides as carbonic anhydrase inhibitors. Archiv Der Pharmazie, 354(2). Portico. doi: https:\/\/doi.org\/10.1002\/ardp.202000230.","DOI":"10.1002\/ardp.202000230"},{"issue":"39","key":"10.1016\/j.bioorg.2026.110384_bb0120","doi-asserted-by":"crossref","first-page":"25104","DOI":"10.1021\/acsomega.0c02675","article-title":"New Route to the Synthesis of Benzamide-Based 5-Aminopyrazoles and Their Fused Heterocycles Showing Remarkable Antiavian Influenza Virus Activity","volume":"5","author":"Hebishy","year":"2020","journal-title":"ACS Omega"},{"issue":"6","key":"10.1016\/j.bioorg.2026.110384_bb0125","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0960-894X(03)00014-3","article-title":"Benzamide derivatives as blockers of Kv1.3 ion channel. Bioorganic &Amp; Medicinal","volume":"13","author":"Miao","year":"2003","journal-title":"Chemistry Letters"},{"issue":"14","key":"10.1016\/j.bioorg.2026.110384_bb0130","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.1016\/j.bmcl.2008.05.107","article-title":"Corrigendum to \u201cN-Pyridin-3-yl- and N-quinolin-3-yl-benzamides: Modulators of Human Vanilloid Receptor 1 (TRPV1)\u201d [Bioorg. Med. Chem. Lett. 18 (2008) 2730\u20132734]","volume":"18","author":"Jetter","year":"2008","journal-title":"Bioorganic &Amp; Medicinal Chemistry Letters"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110384_bb0135","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1021\/acsomega.0c05690","article-title":"Design and Synthesis of \u201cChloropicolinate Amides and Urea Derivatives\u201d as Novel Inhibitors for Mycobacterium tuberculosis","volume":"6","author":"Konduri","year":"2021","journal-title":"ACS Omega"},{"issue":"4","key":"10.1016\/j.bioorg.2026.110384_bb0140","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/s11172-019-2473-8","article-title":"Ureas bearing alkylaromatic moieties: their synthesis and biological activity","volume":"68","author":"Smolobochkin","year":"2019","journal-title":"Russian Chemical Bulletin"},{"issue":"7","key":"10.1016\/j.bioorg.2026.110384_bb0145","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1007\/s00044-014-0930-3","article-title":"Unsymmetrical 1,3-disubstituted urea derivatives as \u03b1-chymotrypsin inhibitors","volume":"23","author":"Perveen","year":"2014","journal-title":"Medicinal Chemistry Research"},{"key":"10.1016\/j.bioorg.2026.110384_bb0150","doi-asserted-by":"crossref","unstructured":"Agrawal, S. K., Sathe, M., Halve, A. K., & Kaushik, M. P. (2012). Dibutylphosphate (DBP) mediated synthesis of cyclic N,N\u2032-disubstituted urea derivatives from amino esters: a comparative study. Tetrahedron Letters, 53(45), 5996\u20135999. doi: https:\/\/doi.org\/10.1016\/j.tetlet.2012.08.083.","DOI":"10.1016\/j.tetlet.2012.08.083"},{"issue":"21","key":"10.1016\/j.bioorg.2026.110384_bb0155","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1080\/00397911.2010.517372","article-title":"Convenient Synthesis of Sorafenib and Its Derivatives","volume":"41","author":"Zhang","year":"2011","journal-title":"Synthetic Communications"},{"key":"10.1016\/j.bioorg.2026.110384_bb0160","article-title":"Heterocycles as versatile building blocks in different synthetic strategies","volume":"395-415","author":"Fahmy","year":"2006","journal-title":"ARKIVOC (vii)"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110384_bb0165","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2174\/187152106776359048","article-title":"Medicinal Chemistry of Ureido Derivatives as Anti-Infectives","volume":"5","author":"Batra","year":"2006","journal-title":"Anti-Infective Agents in Medicinal Chemistry"},{"key":"10.1016\/j.bioorg.2026.110384_bb0170","article-title":"Synthesis of mono-and N","volume":"8-14","author":"Katritzky","year":"2003","journal-title":"N-disubstituted ureas. ARKIVOC (viii)"},{"issue":"10","key":"10.1016\/j.bioorg.2026.110384_bb0175","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.3390\/polym13101583","article-title":"Ureido Functionalization through Amine-Urea Transamidation under Mild Reaction Conditions","volume":"13","author":"Guerrero-Alburquerque","year":"2021","journal-title":"Polymers"},{"key":"10.1016\/j.bioorg.2026.110384_bb0180","doi-asserted-by":"crossref","first-page":"7076","DOI":"10.1039\/D5MA00711A","article-title":"Selective and sustainable nitro reduction and reductive N-alkylation using a recyclable V2O5\/TiO2 catalyst for amine synthesis","volume":"6","author":"Rahul","year":"2025","journal-title":"Mater. Adv."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110384_bb0185","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3390\/ph15060717","article-title":"The Diverse Biological Activity of Recently Synthesized Nitro Compounds","volume":"15","author":"Noriega","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110384_bb0190","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3390\/biom11020267","article-title":"Nitroaromatic Antibiotics as Nitrogen Oxide Sources","volume":"11","author":"Rice","year":"2021","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.bioorg.2026.110384_bb0195","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3390\/molecules25030673","article-title":"Recent Progress in Nitro-Promoted Direct Functionalization of Pyridones and Quinolones","volume":"25","author":"Hao","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110384_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2020.595246","article-title":"Editorial: Nitro Compounds as Versatile Building Blocks for the Synthesis of Pharmaceutically Relevant Substances","volume":"8","author":"Sukhorukov","year":"2020","journal-title":"Frontiers in Chemistry"},{"issue":"16","key":"10.1016\/j.bioorg.2026.110384_bb0205","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.3390\/molecules25163680","article-title":"A Walk through Recent Nitro Chemistry Advances","volume":"25","author":"Nishiwaki","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110384_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2020.00030","article-title":"The Stereoselective Nitro-Mannich Reaction in the Synthesis of Active Pharmaceutical Ingredients and Other Biologically Active Compounds","volume":"8","author":"Faisca Phillips","year":"2020","journal-title":"Frontiers in Chemistry"},{"key":"10.1016\/j.bioorg.2026.110384_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2026.109792","article-title":"Design, synthesis, and in silico study of VEGFR-2 and HDAC dual acting quinazoline based molecules for anticancer evaluation","volume":"175","author":"Abdallah","year":"2026","journal-title":"Bioorganic Chemistry"},{"key":"10.1016\/j.bioorg.2026.110384_bb0220","doi-asserted-by":"crossref","unstructured":"Liu WB, Song J, Zhang SY. A short overview of dual targeting HDAC inhibitors (2025). Future Med Chem. 17, 1, 5-7, doi: 10.1080\/17568919.2024.2437975.","DOI":"10.1080\/17568919.2024.2437975"},{"issue":"262","key":"10.1016\/j.bioorg.2026.110384_bb0225","article-title":"Discovery of benzamide-based PI3K\/HDAC dual inhibitors with marked pro-apoptosis activity in lymphoma cells","volume":"15","author":"Deng","year":"2023","journal-title":"Eur J Med Chem."},{"issue":"222","key":"10.1016\/j.bioorg.2026.110384_bb0230","article-title":"A first-in-class anticancer dual HDAC2\/FAK inhibitors bearing hydroxamates\/benzamides capped by pyridinyl-1,2,4-triazoles","volume":"15","author":"Mustafa","year":"2022","journal-title":"Eur J Med Chem."},{"key":"#cr-split#-10.1016\/j.bioorg.2026.110384_bb0235.1","unstructured":"Calum S, Ruby H, Josh T. C, Sudhir T (2025). The enzyme glycogen synthase kinase-3 is associated with specific forms of oncogenesis"},{"key":"#cr-split#-10.1016\/j.bioorg.2026.110384_bb0235.2","doi-asserted-by":"crossref","unstructured":"what more do we need to know to achieve clinical benefit?. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1880, 4, 189365. doi: https:\/\/doi.org\/10.1016\/j.bbcan.2025.189365.","DOI":"10.1016\/j.bbcan.2025.189365"},{"key":"10.1016\/j.bioorg.2026.110384_bb0240","doi-asserted-by":"crossref","first-page":"1693805","DOI":"10.3389\/fphar.2025.1693805","article-title":"The dual role of glycogen synthase kinase-3 beta (GSK3\u03b2) in neurodegenerative pathologies: interplay between autophagy and disease progression","volume":"16","author":"Alhassan","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110384_bb0245","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.70028","article-title":"Benzamide-Containing Histone Deacetylase Inhibitors With Anticancer Therapeutic Potential","volume":"358","author":"Song","year":"2025","journal-title":"Archiv der Pharmazie"},{"key":"10.1016\/j.bioorg.2026.110384_bb0250","doi-asserted-by":"crossref","unstructured":"Ambati H, Ganesh R, TP, Suvankar B, Darakhshan B, Sanjeev R, Sravani P, Swati B, Nilanjan A, Balaram G (2025). Design and synthesis of pyridine-based benzamides as potent HDAC3 inhibitors as an armament against breast cancer with in vivo validation. European Journal of Medicinal Chemistry 291, 117636, doi: https:\/\/doi.org\/10.1016\/j.ejmech.2025.117636.","DOI":"10.1016\/j.ejmech.2025.117636"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110384_bb0255","doi-asserted-by":"crossref","first-page":"2520612","DOI":"10.1080\/14756366.2025.2520612","article-title":"Development of novel benzamide class I selective lysine deacetylase inhibitors as potent anticancer agents","volume":"40","author":"Gill","year":"2025","journal-title":"J Enzyme Inhib Med Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110384_bb0260","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1039\/D4MD00617H","article-title":"Novel benzenesulfonamides containing a dual triazole moiety with selective carbonic anhydrase inhibition and anticancer activity","volume":"16","author":"Buza","year":"2025","journal-title":"RSC Medicinal Chemistry"},{"key":"10.1016\/j.bioorg.2026.110384_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108689","article-title":"Fluorenyl-phthalimide hybrids as potent aldose reductase inhibitors with selective anticancer activity: Rational design, synthesis, and molecular insights","volume":"163","author":"Gundogdu","year":"2025","journal-title":"Bioorganic Chemistry"},{"key":"10.1016\/j.bioorg.2026.110384_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2026.109085","article-title":"Integrated experimental and computational study of oxime-based derivatives: Antiproliferative evaluation, gene expression, DNA minor groove binding, detailed DFT, docking, and molecular dynamics analyses","volume":"124","author":"Feizi-Dehnayebi","year":"2026","journal-title":"Computational Biology and Chemistry"},{"key":"10.1016\/j.bioorg.2026.110384_bb0275","doi-asserted-by":"crossref","unstructured":"D.D. Perrin and W. L. F. Armarego. Pergamon Press, Oxford, 1988. ISBN 0\u201008\u2010034714\u20102, doi: https:\/\/doi.org\/10.1002\/recl.19881071209.","DOI":"10.1002\/recl.19881071209"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110384_bb0280","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/j.bioorg.2026.110384_bb0285","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.comtox.2019.02.004","article-title":"Mechanistic skin penetration model by the COSMOperm method: Routes of permeation, vehicle effects and skin variations in the healthy and compromised skin","volume":"11","author":"Johannes","year":"2019","journal-title":"Computational Toxicology"},{"issue":"21","key":"10.1016\/j.bioorg.2026.110384_bb0290","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1021\/acs.jcim.3c01053","article-title":"SwissParam 2023: a modern web-based tool for efficient small molecule parameterization","volume":"63","author":"Bugnon","year":"2023","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2026.110384_bb0295","doi-asserted-by":"crossref","unstructured":"Zoete V, Cuendet MA, Grosdidier A, Michielin O. SwissParam (2011). a fast force field generation tool for small organic molecules. J. Comput. Chem., 32(11), 2359-68. doi: https:\/\/doi.org\/10.1002\/jcc.21816.","DOI":"10.1002\/jcc.21816"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110384_bb0300","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/jcc.21963","article-title":"MATCH: An atom-typing toolset for molecular mechanics force fields","volume":"33","author":"Yesselman","year":"2011","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2026.110384_bb0305","doi-asserted-by":"crossref","first-page":"W324","DOI":"10.1093\/nar\/gkae300","article-title":"SwissDoc k 2024: major enhancements for small-molecule docking with Attracting Cavities and AutoDock Vina","volume":"52","author":"Bugnon","year":"2024","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/j.bioorg.2026.110384_bb0310","first-page":"1","article-title":"AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings","volume":"61, 8, 389","author":"Eberhardt","year":"2021","journal-title":"J Chem Inf Model."},{"key":"10.1016\/j.bioorg.2026.110384_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108861","article-title":"Chalcone-inspired indole, carbazole, and phenothiazine hybrids as potent aldose reductase inhibitors with selective anticancer potential: Rational design, synthesis, and multi-level characterization","volume":"164","author":"G\u00fcle\u00e7","year":"2025","journal-title":"Bioorganic Chemistry"},{"key":"10.1016\/j.bioorg.2026.110384_bb0320","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nrd4163","article-title":"The role of ligand efficiency metrics in drug discovery","volume":"13","author":"Hopkins","year":"2014","journal-title":"Nat Rev Drug Discov"},{"issue":"18","key":"10.1016\/j.bioorg.2026.110384_bb0325","doi-asserted-by":"crossref","first-page":"9997","DOI":"10.1073\/pnas.96.18.9997","article-title":"The maximal affinity of ligands","volume":"96","author":"Kuntz","year":"1999","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.bioorg.2026.110384_bb0330","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2478\/s11696-012-0266-8","article-title":"Facile synthesis of 3-substituted quinazoline-2,4-dione and 2,3-di-substituted quinazolinone derivatives","volume":"67","author":"Farouk","year":"2013","journal-title":"Chem. Pap."},{"key":"10.1016\/j.bioorg.2026.110384_bb0335","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2478\/s11696-011-0094-2","article-title":"One-pot synthesis and luminescent spectra of 3-allyl substituted quinazoline-2,4-dione derivatives as allyl capping agents","volume":"66","author":"Farouk","year":"2012","journal-title":"Chem. Pap."},{"issue":"34","key":"10.1016\/j.bioorg.2026.110384_bb0340","doi-asserted-by":"crossref","first-page":"23870","DOI":"10.1039\/D3RA03378C","article-title":"Phthalic anhydride (PA): a valuable substrate in organic transformations","volume":"13","author":"Nikoofar","year":"2023","journal-title":"RSC Advances"},{"key":"10.1016\/j.bioorg.2026.110384_bb0345","unstructured":"Vogel A.I. (1989). Textbook of Practical Organic Chemistry, 5th Ed., Longmans Green and Co. Ltd., London."},{"key":"10.1016\/j.bioorg.2026.110384_bb0350","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s44371-026-00675-9","article-title":"Ultrasonic-assisted Lossen rearrangement of N-phenylsulfonyloxy succinimide: synthesis, and in silico ADME predictions pharmacokinetics, and druglikenes of 3-ureidopropanamide derivatives & pyrimidine-2,4-diol derivative","volume":"3","author":"Farouk","year":"2026","journal-title":"Discov. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2026.110384_bb0355","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1246\/bcsj.50.2678","article-title":"Phthalimides. I. Base-catalyzed Lossen Rearrangement and Acid-catalyzed Beckmann Rearrangement with N-(Arylsulfonyloxy)phthalimides","volume":"50","author":"Fahmy","year":"1977","journal-title":"Bulletin of the Chemical Society of Japan"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110384_bb0360","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1021\/acsorginorgau.5c00120","article-title":"Synthetic Applications of Hydroxamic Acids and Their Derivatives in Organic Chemistry","volume":"6","author":"Wang","year":"2026","journal-title":"ACS Organic &Amp; Inorganic Au"},{"issue":"7","key":"10.1016\/j.bioorg.2026.110384_bb0365","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/s41557-025-01845-5","article-title":"A biocompatible Lossen rearrangement in Escherichia coli","volume":"17","author":"Johnson","year":"2025","journal-title":"Nature Chemistry"},{"issue":"34","key":"10.1016\/j.bioorg.2026.110384_bb0370","doi-asserted-by":"crossref","first-page":"21843","DOI":"10.1021\/acsomega.1c03628","article-title":"Hydroxamic Acid Derivatives: From Synthetic Strategies to Medicinal Chemistry Applications","volume":"6","author":"Citarella","year":"2021","journal-title":"ACS Omega"},{"issue":"22","key":"10.1016\/j.bioorg.2026.110384_bb0375","first-page":"5420","article-title":"The Lossen rearrangement from free hydroxamic acids. Organic &Amp; Biomolecular","volume":"17","author":"Thomas","year":"2019","journal-title":"Chemistry"},{"issue":"9","key":"10.1016\/j.bioorg.2026.110384_bb0380","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1016\/S0021-9258(19)76925-7","article-title":"Application of the Lossen Rearrangement of Dinitrophenylhydroxamates to Analysis of Carboxyl Groups in Model Compounds and Gelatin","volume":"235","author":"Gallop","year":"1960","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.bioorg.2026.110384_bb0385","doi-asserted-by":"crossref","unstructured":"VanVerst, M. E., Bell, C. L., & Bauer, L. (1979). Amine\u2010induced lossen rearrangements of 3\u2010hydroxy\u20105,6\u2010dihydrouracil and N\u2010hydroxysuccinimide benzenesulfontes. Journal of Heterocyclic Chemistry, 16(7), 1329\u20131333. Portico. doi: https:\/\/doi.org\/10.1002\/jhet.5570160708.","DOI":"10.1002\/jhet.5570160708"},{"issue":"6","key":"10.1016\/j.bioorg.2026.110384_bb0390","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/anie.197403761","article-title":"The Chemistry of Hydroxamic Acids and N\u2010Hydroxyimides","volume":"13","author":"Bauer","year":"1974","journal-title":"Angewandte Chemie International Edition in English"},{"issue":"2-3","key":"10.1016\/j.bioorg.2026.110384_bb0395","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/jlac.18721610219","article-title":"Ueber Benzoylderivate des Hydroxylamins","volume":"161","author":"Lossen","year":"1872","journal-title":"Justus Liebigs Annalen Der Chemie"},{"issue":"19","key":"10.1016\/j.bioorg.2026.110384_bb0400","doi-asserted-by":"crossref","first-page":"5196","DOI":"10.1021\/ja01576a033","article-title":"Colorless and Yellow Forms of N-Hydroxyphthalimide","volume":"79","author":"Roderick","year":"1957","journal-title":"Journal of the American Chemical Society"},{"issue":"12","key":"10.1016\/j.bioorg.2026.110384_bb0405","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1021\/jo01106a631","article-title":"Notes - Reaction of Hydrazine with Acetic Acid at 25 degrees","volume":"23","author":"Harris","year":"1958","journal-title":"The Journal of Organic Chemistry"},{"issue":"4","key":"10.1016\/j.bioorg.2026.110384_bb0410","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrd4578","article-title":"Mitigating risk in academic preclinical drug discovery","volume":"14","author":"Dahlin","year":"2015","journal-title":"Nature Reviews Drug Discovery"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110384_bb0415","first-page":"1","article-title":"Trends in oral small-molecule drug discovery and product development based on product launches before and after the Rule of Five","volume":"28","author":"Sven","year":"2023","journal-title":"Drug Discovery Today"},{"issue":"4","key":"10.1016\/j.bioorg.2026.110384_bb0420","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.ipha.2024.01.010","article-title":"The importance of in-silico studies in drug discovery","volume":"2","author":"Miah","year":"2024","journal-title":"Intelligent Pharmacy"},{"key":"10.1016\/j.bioorg.2026.110384_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2025.102941","article-title":"Eugenol-loaded zinc oxide nanoparticles enhance paclitaxel sensitivity in breast Cancer cells: A combined synergistic nanomedicine and theoretical approach","volume":"19","author":"Rowhani","year":"2026","journal-title":"Results in Chemistry"},{"key":"10.1016\/j.bioorg.2026.110384_bb0430","article-title":"Phthalimide\u2013benzoic acid hybrids as potent aldose reductase inhibitors: Synthesis, enzymatic kinetics, and in silico characterization. Bioorganic &Amp","volume":"131","author":"Hoti","year":"2025","journal-title":"Medicinal Chemistry"},{"key":"10.1016\/j.bioorg.2026.110384_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2025.102992","article-title":"Tetrazole-based fluorescent probe for sensitive detection of Cu2+: photoluminescence, biological activity, DNA\/BSA interaction, and theoretical insights","volume":"20","author":"Farzandi","year":"2026","journal-title":"Results in Chemistry"},{"issue":"11","key":"10.1016\/j.bioorg.2026.110384_bb0440","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.3390\/ph18111685","article-title":"Multitarget-Directed Ligands for Alzheimer\u2019s Disease: Recent Novel MTDLs and Mechanistic Insights","volume":"18","author":"Almaghrabi","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"3","key":"10.1016\/j.bioorg.2026.110384_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.103904","article-title":"Recent advances in multitarget-directed ligands via in silico drug discovery","volume":"29","author":"Maddeboina","year":"2024","journal-title":"Drug Discov Today."},{"key":"10.1016\/j.bioorg.2026.110384_bb0450","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.980141","article-title":"Editorial: Multi-target directed ligands for the treatment of cancer","volume":"12","author":"Brindisi","year":"2022","journal-title":"Frontiers in Oncology"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110384_bb0455","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/17460441.2018.1413089","article-title":"Improving the efficacy-safety balance of polypharmacology in multi-target drug discovery","volume":"13","author":"Ravikumar","year":"2017","journal-title":"Expert Opinion on Drug Discovery"},{"key":"10.1016\/j.bioorg.2026.110384_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118304","article-title":"Click-modifiable isatin hydrazones as COX-2, VEGFR-2, and carbonic anhydrase inhibitors: A multi-target approach to cancer therapy","volume":"302","author":"El-Attar","year":"2026","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110384_bb0465","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s12672-024-01195-7","article-title":"Novel therapeutic agents in clinical trials: emerging approaches in cancer therapy","volume":"15","author":"Joshi","year":"2024","journal-title":"Discov Oncol."},{"key":"10.1016\/j.bioorg.2026.110384_bb0470","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1021\/acs.jmedchem.5c03037","article-title":"First-in-Class Dual PDGFR\/Carbonic Anhydrase IX\/XII Inhibitors: 6,7-Dimethoxyquinoline-Sulfonamides as Promising Antileukemic Agents","volume":"12, 69, 3","author":"Roshdy","year":"2026","journal-title":"J Med Chem."},{"issue":"115935","key":"10.1016\/j.bioorg.2026.110384_bb0475","first-page":"0223","article-title":"HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents","volume":"263","author":"Waitman","year":"2024","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/j.bioorg.2026.110384_bb0480","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41577-023-00877-7","article-title":"Protein kinases: drug targets for immunological disorders","volume":"12","author":"Castelo-Soccio","year":"2023","journal-title":"Nat Rev Immunol."},{"key":"10.1016\/j.bioorg.2026.110384_bb0485","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.3390\/cells11182898","article-title":"GSK3 Is a Central Player in Retinal Degenerative Diseases but a Challenging Therapeutic Target","volume":"11","author":"Hottin","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bioorg.2026.110384_bb0490","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/930710","article-title":"GSK-3\u03b2: A Bifunctional Role in Cell Death Pathways","volume":"2012","author":"Jacobs","year":"2012","journal-title":"Int J Cell Biol."},{"key":"10.1016\/j.bioorg.2026.110384_bb0495","doi-asserted-by":"crossref","first-page":"44701","DOI":"10.1074\/jbc.M206047200","article-title":"Central role of glycogen synthase kinase-3beta in endoplasmic reticulum stress-induced caspase-3 activation","volume":"22, 277, 47","author":"Song","year":"2002","journal-title":"J Biol Chem."},{"key":"10.1016\/j.bioorg.2026.110384_bb0500","doi-asserted-by":"crossref","first-page":"337","DOI":"10.4161\/cbt.9.5.11217","article-title":"Mitogen activated protein kinase phosphatases and cancer","volume":"1, 9, 5","author":"Haagenson","year":"2010","journal-title":"Cancer Biol Ther."},{"issue":"7","key":"10.1016\/j.bioorg.2026.110384_bb0505","doi-asserted-by":"crossref","first-page":"10893","DOI":"10.1007\/s00210-026-05076-4","article-title":"Synergistic anticancer effects of tamoxifen in combination with fisetin and chrysin on breast cancer cells: insights into viability, migration, and apoptosis","volume":"399","author":"Karami-Dehkordi","year":"2026","journal-title":"Naunyn-Schmiedeberg\u2019s Archives of Pharmacology"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682600920X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682600920X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:57:22Z","timestamp":1791406642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004520682600920X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":102,"alternative-id":["S004520682600920X"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110384","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, one-pot synthesis, and structural characterization of novel 2-ureido-6-nitrobenzamide derivatives as MTDLs targeting HDAC8\/epigenetic-kinase networks","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110384","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110384"}}